GlassScriptPhysician profile
Wajid Siddiqui
NPI 1669647889
$1,804.79
in general payments reported to CMS, 2019-2025
10 companies · $42.61 in 2025
The $42.61 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,360 · 2022: $122 · 2023: $181 · 2024: $99.21 · 2025: $42.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.35 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipla USA INC. | $1,302.18 | 2021 | |
| Gilead Sciences, INC. | $202.26 | 2021-2023 | Veklury |
| Merck Sharp & Dohme LLC | $104.56 | 2022-2025 | Zerbaxa, Dificid, Recarbrio |
| Abbvie INC. | $42.04 | 2022-2024 | |
| La Jolla Pharmaceutical Company | $38.93 | 2021-2024 | Xacduro |
| Astellas Pharma US INC | $33.42 | 2023-2024 | Cresemba |
| Baxter Healthcare | $23.90 | 2023 | Hillrom - Life 2000 Ventilation System |
| Melinta Therapeutics, LLC | $22.20 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.54 | 2023 | Nuzyra |
| Philips North America LLC | $15.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wajid Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.